• Prescribing Information and Adverse Event reporting statement can be found at the bottom of this page

Learn more about our featured products

Support for you and your practice

Get more from GSKpro

Access expert-led webinars, stay informed with the latest product updates, and relevant therapeutic insights, and access patient-focused resources to help you deliver the highest standard of care.

Prescribing information

BLENREP prescribing information

SHINGRIX prescribing information (GB)

Adverse events should be reported. Reporting forms and information can be found at https://yellowcard.mhra.gov.uk or search for MHRA Yellowcard in the Google Play or Apple App Store. Adverse events should also be reported to GSK on 0800 221 441 or UKSafety@gsk.com.

June 2025 | PM-GB-NA-WCNT-210014 (V11.0)